-
1
-
-
41349099104
-
Cancer statistics, 2008
-
Jermal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jermal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
-
2
-
-
77953914799
-
Current management of advanced and metastatic renal cell carcinoma
-
Ather M.H., Masood N., Siddiqui T. Current management of advanced and metastatic renal cell carcinoma. Urol J 2010, 7:1-9.
-
(2010)
Urol J
, vol.7
, pp. 1-9
-
-
Ather, M.H.1
Masood, N.2
Siddiqui, T.3
-
3
-
-
0033978220
-
Systemic therapy for renal cell carcinoma
-
Motzer R.J., Russo P. Systemic therapy for renal cell carcinoma. J Urol 2000, 163:408-417.
-
(2000)
J Urol
, vol.163
, pp. 408-417
-
-
Motzer, R.J.1
Russo, P.2
-
4
-
-
18544385949
-
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials
-
Bacoyiannis C., Dimopoulos M.A., Kalofonos H.P., Nicolaides C., Aravantinos G., Bafaloukos D., et al. Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials. Oncology 2002, 63:130-138.
-
(2002)
Oncology
, vol.63
, pp. 130-138
-
-
Bacoyiannis, C.1
Dimopoulos, M.A.2
Kalofonos, H.P.3
Nicolaides, C.4
Aravantinos, G.5
Bafaloukos, D.6
-
5
-
-
0032900953
-
Biochemical, cellular, and pharmacological aspects of the multidrug transporter
-
Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999, 39:361-398.
-
(1999)
Annu Rev Pharmacol Toxicol
, vol.39
, pp. 361-398
-
-
Ambudkar, S.V.1
Dey, S.2
Hrycyna, C.A.3
Ramachandra, M.4
Pastan, I.5
Gottesman, M.M.6
-
6
-
-
0027202032
-
Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma
-
Naito S., Sakamoto N., Kotoh S., Goto K., Matsumoto T., Kumazawa J. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma. Eur Urol 1993, 24:156-160.
-
(1993)
Eur Urol
, vol.24
, pp. 156-160
-
-
Naito, S.1
Sakamoto, N.2
Kotoh, S.3
Goto, K.4
Matsumoto, T.5
Kumazawa, J.6
-
7
-
-
0025007511
-
Pharmacology of drugs that alter multidrug resistance in cancer
-
Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990, 42:155-199.
-
(1990)
Pharmacol Rev
, vol.42
, pp. 155-199
-
-
Ford, J.M.1
Hait, W.N.2
-
8
-
-
0027411956
-
Cell-cell communication and growth control of normal and cancer cells: evidence and hypothesis
-
Mesnil M., Yamasaki H. Cell-cell communication and growth control of normal and cancer cells: evidence and hypothesis. Mol Carcinog 1993, 7:14-17.
-
(1993)
Mol Carcinog
, vol.7
, pp. 14-17
-
-
Mesnil, M.1
Yamasaki, H.2
-
9
-
-
0036873006
-
Connexins and cancer
-
Mesnil M. Connexins and cancer. Biol Cell 2002, 94:493-500.
-
(2002)
Biol Cell
, vol.94
, pp. 493-500
-
-
Mesnil, M.1
-
10
-
-
0030809793
-
Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes
-
Duflot-Dancer A., Mesnil M., Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 1997, 15:2151-2158.
-
(1997)
Oncogene
, vol.15
, pp. 2151-2158
-
-
Duflot-Dancer, A.1
Mesnil, M.2
Yamasaki, H.3
-
11
-
-
19944381865
-
Connexin 32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line
-
Fujimoto E., Sato H., Shirai S., Nagashima Y., Fukumoto K., Hagiwara H., et al. Connexin 32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line. Oncogene 2005, 24:3684-3690.
-
(2005)
Oncogene
, vol.24
, pp. 3684-3690
-
-
Fujimoto, E.1
Sato, H.2
Shirai, S.3
Nagashima, Y.4
Fukumoto, K.5
Hagiwara, H.6
-
12
-
-
0033900009
-
Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication
-
Mesnil M., Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res 2000, 60:3989-3999.
-
(2000)
Cancer Res
, vol.60
, pp. 3989-3999
-
-
Mesnil, M.1
Yamasaki, H.2
-
13
-
-
33947155835
-
Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells
-
Sato H., Senba H., Virgona N., Fukumoto K., Ishida T., Hagiwara H., et al. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells. Mol Carcinog 2007, 46:215-224.
-
(2007)
Mol Carcinog
, vol.46
, pp. 215-224
-
-
Sato, H.1
Senba, H.2
Virgona, N.3
Fukumoto, K.4
Ishida, T.5
Hagiwara, H.6
-
14
-
-
0038693736
-
Down-regulation of connexin 32 gene expression through DNA methylation in a human renal cell carcinoma cell
-
Hirai A., Yano T., Nishikawa K., Suzuki K., Asano R., Satoh H., et al. Down-regulation of connexin 32 gene expression through DNA methylation in a human renal cell carcinoma cell. Am J Nephrol 2003, 23:172-177.
-
(2003)
Am J Nephrol
, vol.23
, pp. 172-177
-
-
Hirai, A.1
Yano, T.2
Nishikawa, K.3
Suzuki, K.4
Asano, R.5
Satoh, H.6
-
15
-
-
1642428195
-
Hypermethylation of the CpG island of connexin 32, a candidate tumour suppressor gene in renal cell carcinomas from hemodialysis patients
-
Yano T., Ito F., Kobayashi K., Yonezawa Y., Suzuki K., Asano R., et al. Hypermethylation of the CpG island of connexin 32, a candidate tumour suppressor gene in renal cell carcinomas from hemodialysis patients. Cancer Lett 2004, 208:137-142.
-
(2004)
Cancer Lett
, vol.208
, pp. 137-142
-
-
Yano, T.1
Ito, F.2
Kobayashi, K.3
Yonezawa, Y.4
Suzuki, K.5
Asano, R.6
-
16
-
-
41649107484
-
5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of connexin 32 gene
-
Hagiwara H., Sato H., Ohde Y., Takano Y., Seki T., Ariga T., et al. 5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of connexin 32 gene. Br J Pharmacol 2008, 153:1373-1381.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 1373-1381
-
-
Hagiwara, H.1
Sato, H.2
Ohde, Y.3
Takano, Y.4
Seki, T.5
Ariga, T.6
-
17
-
-
33750596313
-
Epigenetic cancer therapy makes headway
-
Mack G.S. Epigenetic cancer therapy makes headway. J Natl Cancer Inst 2006, 98:1443-1444.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1443-1444
-
-
Mack, G.S.1
-
18
-
-
13444274764
-
Modulation of P-glycoprotein function by amlodipine derivatives in brain microvessel endothelial cells of rats
-
Ji B.S., He L., Liu G.Q. Modulation of P-glycoprotein function by amlodipine derivatives in brain microvessel endothelial cells of rats. Acta Pharmacol Sin 2005, 26:166-170.
-
(2005)
Acta Pharmacol Sin
, vol.26
, pp. 166-170
-
-
Ji, B.S.1
He, L.2
Liu, G.Q.3
-
19
-
-
0037041899
-
Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3
-
Yano T., Zissel G., Muller-Qernheim J., Shin S.J., Satoh H., Ichikawa T. Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3. FEBS Lett 2002, 518:154-158.
-
(2002)
FEBS Lett
, vol.518
, pp. 154-158
-
-
Yano, T.1
Zissel, G.2
Muller-Qernheim, J.3
Shin, S.J.4
Satoh, H.5
Ichikawa, T.6
-
20
-
-
0030762450
-
Increased frequency of P-glycoprotein gene amplification in colchicine-resistant Rat-1 clones transformed by v-src
-
Lin T., Trent J.M., Milliken D., Shimm D.S., Donaldson R., Hill A.B. Increased frequency of P-glycoprotein gene amplification in colchicine-resistant Rat-1 clones transformed by v-src. Cancer Genet Cytogenet 1997, 96:157-165.
-
(1997)
Cancer Genet Cytogenet
, vol.96
, pp. 157-165
-
-
Lin, T.1
Trent, J.M.2
Milliken, D.3
Shimm, D.S.4
Donaldson, R.5
Hill, A.B.6
-
21
-
-
0034630482
-
Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein
-
Kang C.D., Ahn B.K., Jeong C.S., Kim K.W., Lee H.J., Yoo S.D., et al. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Exp Cell Res 2000, 256:300-307.
-
(2000)
Exp Cell Res
, vol.256
, pp. 300-307
-
-
Kang, C.D.1
Ahn, B.K.2
Jeong, C.S.3
Kim, K.W.4
Lee, H.J.5
Yoo, S.D.6
-
22
-
-
0035133227
-
Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1
-
Kim A.H., Khursigara G., Sun X., Franke T.F., Chao M.V. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 2001, 21:893-901.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 893-901
-
-
Kim, A.H.1
Khursigara, G.2
Sun, X.3
Franke, T.F.4
Chao, M.V.5
-
23
-
-
0042591363
-
Transcription factor c-Jun activation represses mdr-1 gene expression
-
Miao Z.H., Ding J. Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res 2003, 63:4527-4532.
-
(2003)
Cancer Res
, vol.63
, pp. 4527-4532
-
-
Miao, Z.H.1
Ding, J.2
-
24
-
-
65749090235
-
Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosis
-
Chu R., Upreti M., Ding W.X., Yin X.M., Chambers T.C. Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosis. Biochem Pharmacol 2009, 78:241-248.
-
(2009)
Biochem Pharmacol
, vol.78
, pp. 241-248
-
-
Chu, R.1
Upreti, M.2
Ding, W.X.3
Yin, X.M.4
Chambers, T.C.5
-
25
-
-
3142676384
-
Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2
-
Fujimoto E., Satoh H., Negishi E., Ueno K., Nagashima Y., Hagiwara K., et al. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2. Mol Carcinog 2004, 40:135-142.
-
(2004)
Mol Carcinog
, vol.40
, pp. 135-142
-
-
Fujimoto, E.1
Satoh, H.2
Negishi, E.3
Ueno, K.4
Nagashima, Y.5
Hagiwara, K.6
-
26
-
-
0029813627
-
Cx32 gene mutation in a chemically induced rat liver tumor
-
Omori Y., Krutovskikh V., Mironov N., Tsuda H., Yamasaki H. Cx32 gene mutation in a chemically induced rat liver tumor. Carcinogenesis 1996, 17:2077-2080.
-
(1996)
Carcinogenesis
, vol.17
, pp. 2077-2080
-
-
Omori, Y.1
Krutovskikh, V.2
Mironov, N.3
Tsuda, H.4
Yamasaki, H.5
-
27
-
-
0035318550
-
Tamoxifen and colchicines-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study
-
Liu J.H., Yang M.H., Fan F.S., Yen C.C., Wang W.S., Chang Y.H., et al. Tamoxifen and colchicines-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study. Urology 2001, 57:650-654.
-
(2001)
Urology
, vol.57
, pp. 650-654
-
-
Liu, J.H.1
Yang, M.H.2
Fan, F.S.3
Yen, C.C.4
Wang, W.S.5
Chang, Y.H.6
-
28
-
-
0037096732
-
Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene
-
Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002, 62:3387-3394.
-
(2002)
Cancer Res
, vol.62
, pp. 3387-3394
-
-
Comerford, K.M.1
Wallace, T.J.2
Karhausen, J.3
Louis, N.A.4
Montalto, M.C.5
Colgan, S.P.6
-
29
-
-
18844444774
-
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
-
Gary M.J., Zhang J., Ellis L.M., Semenza G.L., Evans D.B., Watowich S.S., et al. HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005, 24:3110-3120.
-
(2005)
Oncogene
, vol.24
, pp. 3110-3120
-
-
Gary, M.J.1
Zhang, J.2
Ellis, L.M.3
Semenza, G.L.4
Evans, D.B.5
Watowich, S.S.6
-
30
-
-
0141994730
-
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades
-
Lu Y., Yu Q., Liu J.H., Zhang J., Wang H., Koul D., et al. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem 2003, 278:40057-40066.
-
(2003)
J Biol Chem
, vol.278
, pp. 40057-40066
-
-
Lu, Y.1
Yu, Q.2
Liu, J.H.3
Zhang, J.4
Wang, H.5
Koul, D.6
-
31
-
-
0035065836
-
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
-
Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001, 2:222-228.
-
(2001)
EMBO Rep
, vol.2
, pp. 222-228
-
-
Tobiume, K.1
Matsuzawa, A.2
Takahashi, T.3
Nishitoh, H.4
Morita, K.5
Takeda, K.6
-
32
-
-
31544463321
-
Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase
-
Zhou J., Liu M., Aneja R., Chandra R., Lage H., Joshi H.C. Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res 2006, 66:445-452.
-
(2006)
Cancer Res
, vol.66
, pp. 445-452
-
-
Zhou, J.1
Liu, M.2
Aneja, R.3
Chandra, R.4
Lage, H.5
Joshi, H.C.6
|